FBFabio Brodskyn

Fabio Brodskyn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fabio Brodskyn has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Fabiano Mesquita Callegari

    Universidade Federal de Sao Paulo/ Escola Paulista de Medicina, São Paulo, Brazil

    3 shared publications
  • Giulianno Molina de Melo

    Universidade Federal de São Paulo, Escola Paulista de Medicina (UNIFESP/EPM), Department of Otorhinolaryngology and Surgery of Head and Neck, São Paulo, SP, Brazil; Hospital Beneficência Portuguesa de São Paulo, Department of Head and Neck Surgery, São Paulo, SP, Brazil

    3 shared publications
  • Murilo Catafesta das Neves

    Universidade Federal de São Paulo (UNIFESP), Department of Otorhinolaryngology and Head and Neck Surgery, São Paulo, SP, Brazil

    3 shared publications
  • Arthur Paredes Gatti

    Department of Otorhinolaryngology and Surgery of Head and Neck, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo 04023-062, SP, Brazil

    2 shared publications
  • Barbara Greggio

    Department of Otorhinolaryngology and Surgery of Head and Neck, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo 04023-062, SP, Brazil

    2 shared publications
  • Fernando Walder

    Department of Otorhinolaryngology and Surgery of Head and Neck, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo 04023-062, SP, Brazil

    2 shared publications

Latest Publications

  • Beyond traditional markers: integrating data mining to identify novel prognostic biomarkers in medullary thyroid carcinoma

    by Fabio Brodskyn, Flavia Facuri Valente, Susan Chow Lindsey, Luiz Antonio de Jesus Rocha Camargo, Fabiano Callegari, Cleber Cp Camacho, Marcio Abrahao

  • Open Access

    Prognostic Factors of Locally Advanced Cutaneous Squamous Cell Carcinoma in Head and Neck Region in Transplanted Patients

    by Giulianno Molina de Melo, Murilo Catafesta das Neves, Rafael Dias Romero, Marcello Rosano, Rodrigo Tadashi Martines, Roberto Massao Takimoto, Barbara Greggio, Marcel das Neves Palumbo, Fabio Brodskyn, Arthur Paredes Gatti, et al.

    Background: Cutaneous squamous cell carcinoma (CSCC) is the second most common neoplasm in humans and the most frequent in Brazil (80% in the head and neck region, 20% mortality). Brazil is a world leader in organ transplants (more than 30,000 transplants in 2019). The risk of transplant patients (Tx) developing CSCC is 65–250 times higher, with deeper infiltration, advanced stage, higher local recurrence, occult metastases, and worse survival. Objective: To investigate the prognostic factors of locally advanced cutaneous squamous cell carcinoma (LACSCC) of the head and neck region in transplant patients. Methods: 16-year retrospective, single-center series of patients with LACSCC in the head and neck region who underwent surgical treatment. Clinical and Tx data, clinical/pathological stage, surgical treatment, parotid/regional and distant metastases, recurrence, and survival were analyzed. Results: 156 patients were included: 69.2% women, 65.3 years; mean primary size: 4.24 cm, 66% T3/T4 tumors, 71% grade 2/3 differentiation, 20.5% transplant recipients, follow-up: 33.6 months. The most affected regions were malar/nasal (28.8%) and auricular (19.2%). Surgeries included wide resection with reconstruction (58.9%), exenteration (14.1%), and temporalectomy (11.5%). Univariate analysis: Recurrence: immunosuppressor drugs (p = 0.009), transplanted (p = 0.006), compromised margin (p = 0.049); Mortality: immunosuppression (p = 0.028), total resection and reconstruction (p = 0.013), stage (8ed) III-IV (p < 0.001), compromised margin (p < 0.001), neck metastasis with extranodal extension (p = 0.018). Multivariate analysis: Recurrence: transplanted HR: 3.69 (p < 0.001), neck metastasis extranodal extension HR: 5.41 (p < 0.001), evolution to distant metastasis HR: 5.27 (p < 0.001); Mortality: neck metastasis extranodal extension HR: 1.94, (p = 0.032), compromised margins HR: 1.87 (p = 0.001). Main surgical procedures: temporalectomy HR: 2.83 (p = 0.007), major rhinectomy HR: 2.47 (p = 0.005); Worst overall survival: Tx compared to NonTx (p = 0.069); Worst survival with recurrence: Tx compared to NonTx (p = 0.005). Conclusions: The LACSCC and transplanted (immunosuppressed) group present low survival, worse prognosis; The formulation of specific guidelines to standardize treatment and predict outcomes on this population are strictly necessary.


  • Open Access

    Prognostic Factors of Locally Advanced Skin Squamous Cell Carcinoma in Head and Neck Region in Transplanted Patients

    by Giulianno Molina de Melo, Murilo Catafesta das Neves, Rafael Dias Romero, Marcello Rosano, Rodrigo Tadashi Martines, Roberto Massao Takimoto, Barbara Greggio, Marcel das Neves Palumbo, Fabio Brodskyn, Arthur Paredes Gatti, et al.

    Background: Squamous cell carcinoma of the skin (SCC) is the second most common neoplasm in humans and the most frequent in Brazil (80% in the head and neck region, 20% mortality). Brazil is a world leader in organ transplants (more than 30,000 transplants in 2019). The risk of transplant patients (Tx) developing SCC is 65-250 times higher, with deeper infiltration, advanced stage, higher local recurrence, occult metastases and worse survival. Objective: To investigate the prognostic factors of locally advanced cutaneous squamous cell carcinoma (LASCC) of the head and neck region in transplant patients. Methods:16-year retrospective, single-center series of patients with LASCC in the head and neck region who underwent surgical treatment. Were analyzed: clinical and Tx data, clinical/pathological stage, surgical treatment, parotid/regional and distant metastases, recurrence and survival. Results: 156 patients were included: 69.2% women, 65.3 years; mean primary size: 4.24 cm, 66% T3/T4 tumors, 71% grade 2/3 differentiation, 20.5% transplant recipients, follow-up: 33.6 months. Most affected regions: malar/nasal (28.8%), auricular (19.2%). Surgeries: wide resection with reconstruction (58.9%), exenteration (14.1%), temporalectomy (11.5%). Univariate analysis: Recurrence: immunosuppressor drugs (p=0.009), transplanted (p=0.006), compromised margin (p=0.049), Mortality: immunosuppression (p=0.028), Total Resection and reconstruction (p=0.013), Stage(8ed) III-IV (p<0.001), compromised margin (p<0.001), neck metastasis with extranodal extension (p=0.018). Multivariate analysis: Recurrence: Transplanted HR:3.69 (p<0.001), Neck metastasis extranodal extension HR:5.41 (p<0.001), Evolution to Distant metastasis HR:5.27 (p<0.001); Mortality: Neck metastasis extranodal extension HR:1.94, (p=0.032), Compromised Margins HR:1.87 (p=0.001), Main Surgical Procedures: Temporalectomy HR:2.83 (p=0.007); Major Rhinectomy HR:2.47 (p=0.005); Worst Overall Survival: Tx compared to NonTx (p=0.069), Worst Survival with Recurrence: Tx compared to NonTx (p=0.005). Conclusions: The LASCC and Transplanted (immunosuppressed) group present low survival, worse prognosis, high risk of recurrence and mortality outcome, formulation of specific guidelines to standardize treatment and predict outcomes in this population are strictly necessary.

  • Open Access

    Thyroid surgery volume – A statement issued by the Brazilian Head and Neck Surgery Society (SBCCP)

    by Fatima Cristina Mendes de Matos, José Guilherme Vartanian, José Carlos Barauna, Ary Serrano Santos, Achilles Alves de Levy Machado, Paola Andrea Galbiatti Pedruzzi, Murilo Catafesta das Neves, Flavio Carneiro Hojaij, Marianne Yumi Nakai, Aline de Oliveira Ribeiro Viana, et al.

    DEAR EDITOR AND COLLEAGUES, Concerning the article “Treatment strategies for low-risk papillary thyroid carcinoma”, published in the Archives of Endocrinology and Metabolism, the Brazilian Society of Head and Neck Surgery (SBCCP) has received with great concern the following statement: “In our opinion, either [partial thyroidectomy] or lobectomy is a good option for patients in Brazil, especially considering the limited number of head and neck surgeons with high surgical volume in the country” (). […] Thyroid surgery volume – A statement [...] DEAR EDITOR AND COLLEAGUES, Concerning the article “Treatment strategies for low-risk papillary thyroid carcinoma”, published in the Archives of Endocrinology and Metabolism, the Brazilian Society of Head and Neck Surgery (SBCCP) has received with great concern the following statement: “In our opinion, either [partial thyroidectomy] or lobectomy is a good option for patients in Brazil, especially considering the limited number of head and neck surgeons with high surgical volume in the country” (). […] Thyroid surgery volume – A statement